Comparison of four commercially available ELISA kits for diagnosis of Fasciola hepatica in Irish cattle.

Fasciola hepatica is the mammalian liver parasite and it produces the result of poor welfare and economic losses in ruminants. While the number of eggs stool is the most common test used for diagnosis, it does not indicate a migration of the adult stage. serological techniques improve the sensitivity at all stages of liver fluke infection. The purpose of this study was to compare four commercially available ELISA test for the diagnosis of F. hepatica.

To this end, we tested three types of samples; (I) is known F. hepatica Status sera from experimental infection for the comparison of sensitivity and specificity, (ii) sera from pre- and post-flukicide-treated (albendazole, closantel, nitroxynil and triclabendazole) beef cattle seropositive for contrast difference before and after treatment, and (iii) samples of bulk tank milk samples from dairy cattle during periods of exposure to high and low F. hepatica to assess seasonal variation with four tests available.

Samples were assayed using ELISA kit provided by four manufacturers (Ildana Biotech, IDEXX, Svanova, and Bio-X). Samples were analyzed simultaneously and in duplicate.In Ildana population control, IDEXX and Bio-X presented 100% sensitivity (Se) and specificity (Sp), Svanovir served Se and Sp of 59% from 96%. In flukicide-treated beef, kit highlighted a decrease in antibody levels 90 days post-treatment in variable degrees.

Finally, bulk milk showed a significant decrease in the value of ELISA between periods of high and low exposure to coincidence with all tests and Sp studied.Se found in this study, confirming that Ildana, IDEXX and Bio-X accurate for detecting exposure to F. hepatica in cattle Ireland. Svanovir Se and Sp in this population, suggesting that larger studies are needed to confirm the characteristics of these tests in the herd of Ireland.

In the use of post-treatment, Bio-X showed a consistent and significant reduction of the value of the ELISA in all treatment groups, which were shown to be a reliable tool to assess the effects of treatment on day 90 post-treatment. Finally, all tests showed to be a reliable tool for monitoring F. hepatica high season and low exposure, using bulk tank milk samples.

Comparison of four commercially available ELISA kits for diagnosis of Fasciola hepatica in Irish cattle.
Comparison of four commercially available ELISA kits for diagnosis of Fasciola hepatica in Irish cattle.

Improved diagnosis of diabetes type Japanese-onset autoimmune first time using a new ELISA kit GADAb, compared to the previously used GADAb RIA kit.

We compared the results of glutamic acid decarboxylase antibody test (GADAb) using radioimmunoassay (RIA) and enzyme-linked immunosorbent assay (ELISA) in subjects with age-onset diabetes mellitus type 1 specimen (T1D) .Serum collected from 1024 cases of Japan (426 laki- male and 598 female) in 2013. the average age of diagnosis was 7 years (0-18 years).

Blood specimen obtained at a mean age of 13 years (2-22 years) .Among 628 subjects whose serum specimens collected within 5 years after diagnosis, positive GADAb level is 47.9% and 69.4% using a RIA using ELISA. The subjects were divided into four groups according to their RIA and ELISA results for GADAb as follows: Gr I (RIA + / ELISA +), Gr II (RIA + / ELISA-), Gr III (RIA- / ELISA +) and Gr IV (RIA – / ELISA-).

Clinical characteristics and genetic Gr Gr I and III were very similar in terms of age at diagnosis, male / female ratio, a relatively high positive rate for both IA-2AB and ZnT8Ab, and HLA genotype. Gr II only contains 5 patients and is characterized by a younger age at diagnosis, a low positive rate for both IA-2AB and ZnT8Ab and unique HLA genotype.

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)

MBS4381198-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)

MBS4381199-002mgWithBSAAzideat02mgmL 0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)

MBS4381199-01mgWithBSAAzideat02mgmL 0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)

MBS4381199-01mgWithoutBSAAzideat1mgmL 0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)

MBS4381199-5x01mgWithBSAAzideat02mgmL 5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)

MBS4381199-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

Traumatic Brain Injury Biomarker Antibody Sampler Kit

HAK21057 1 Kit Ask for price

YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)

MBS4381128-002mgWithBSAAzideat02mgmL 0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230

YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)

MBS4381128-01mgWithBSAAzideat02mgmL 0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405

YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)

MBS4381128-01mgWithoutBSAAzideat1mgmL 0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405

YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)

MBS4381128-5x01mgWithBSAAzideat02mgmL 5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725

YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)

MBS4381128-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)

MBS4381129-002mgWithBSAAzideat02mgmL 0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230

YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)

MBS4381129-01mgWithBSAAzideat02mgmL 0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405

YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)

MBS4381129-01mgWithoutBSAAzideat1mgmL 0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405

YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)

MBS4381129-5x01mgWithBSAAzideat02mgmL 5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725

YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)

MBS4381129-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), 1mg/mL

BNUM2759-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), 1mg/mL

BNUM2760-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), 0.2mg/mL

BNUB2759-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), 0.2mg/mL

BNUB2759-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), 0.2mg/mL

BNUB2760-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), 0.2mg/mL

BNUB2760-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)

MBS4380253-002mgWithBSAAzideat02mgmL 0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230

TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)

MBS4380253-01mgWithBSAAzideat02mgmL 0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405

TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)

MBS4380253-01mgWithoutBSAAzideat1mgmL 0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405

TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)

MBS4380253-5x01mgWithBSAAzideat02mgmL 5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725

TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)

MBS4380253-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)

MBS4380254-002mgWithBSAAzideat02mgmL 0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230

TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)

MBS4380254-01mgWithBSAAzideat02mgmL 0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405

TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)

MBS4380254-01mgWithoutBSAAzideat1mgmL 0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405

TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)

MBS4380254-5x01mgWithBSAAzideat02mgmL 5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725

TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)

MBS4380254-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 1mg/mL

BNUM2430-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 0.2mg/mL

BNUB2430-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 0.2mg/mL

BNUB2430-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), 1mg/mL

BNUM2570-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), 0.2mg/mL

BNUB2570-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), 0.2mg/mL

BNUB2570-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), Biotin conjugate, 0.1mg/mL

BNCB2759-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), Biotin conjugate, 0.1mg/mL

BNCB2759-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), Biotin conjugate, 0.1mg/mL

BNCB2760-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), Biotin conjugate, 0.1mg/mL

BNCB2760-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF568 conjugate, 0.1mg/mL

BNC682759-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF568 conjugate, 0.1mg/mL

BNC682759-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF568 conjugate, 0.1mg/mL

BNC682760-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF568 conjugate, 0.1mg/mL

BNC682760-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF594 conjugate, 0.1mg/mL

BNC942759-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF594 conjugate, 0.1mg/mL

BNC942759-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF594 conjugate, 0.1mg/mL

BNC942760-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF594 conjugate, 0.1mg/mL

BNC942760-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF647 conjugate, 0.1mg/mL

BNC472759-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF647 conjugate, 0.1mg/mL

BNC472759-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF647 conjugate, 0.1mg/mL

BNC472760-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF647 conjugate, 0.1mg/mL

BNC472760-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF488A conjugate, 0.1mg/mL

BNC882759-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF488A conjugate, 0.1mg/mL

BNC882759-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF488A conjugate, 0.1mg/mL

BNC882760-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF488A conjugate, 0.1mg/mL

BNC882760-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF640R conjugate, 0.1mg/mL

BNC402759-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF640R conjugate, 0.1mg/mL

BNC402759-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF640R conjugate, 0.1mg/mL

BNC402760-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF640R conjugate, 0.1mg/mL

BNC402760-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF405S conjugate, 0.1mg/mL

BNC042759-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF405S conjugate, 0.1mg/mL

BNC042759-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF405S conjugate, 0.1mg/mL

BNC042760-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF405S conjugate, 0.1mg/mL

BNC042760-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), 1mg/mL

BNUM1943-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), 0.2mg/mL

BNUB1943-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), 0.2mg/mL

BNUB1943-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), Biotin conjugate, 0.1mg/mL

BNCB2430-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), Biotin conjugate, 0.1mg/mL

BNCB2430-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF568 conjugate, 0.1mg/mL

BNC682430-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF568 conjugate, 0.1mg/mL

BNC682430-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF594 conjugate, 0.1mg/mL

BNC942430-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF594 conjugate, 0.1mg/mL

BNC942430-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF647 conjugate, 0.1mg/mL

BNC472430-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF647 conjugate, 0.1mg/mL

BNC472430-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), Biotin conjugate, 0.1mg/mL

BNCB2570-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), Biotin conjugate, 0.1mg/mL

BNCB2570-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF568 conjugate, 0.1mg/mL

BNC682570-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF568 conjugate, 0.1mg/mL

BNC682570-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF488A conjugate, 0.1mg/mL

BNC882430-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF488A conjugate, 0.1mg/mL

BNC882430-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF594 conjugate, 0.1mg/mL

BNC942570-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF594 conjugate, 0.1mg/mL

BNC942570-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF640R conjugate, 0.1mg/mL

BNC402430-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF640R conjugate, 0.1mg/mL

BNC402430-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF647 conjugate, 0.1mg/mL

BNC472570-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF647 conjugate, 0.1mg/mL

BNC472570-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF405S conjugate, 0.1mg/mL

BNC042430-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF405S conjugate, 0.1mg/mL

BNC042430-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF488A conjugate, 0.1mg/mL

BNC882570-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF488A conjugate, 0.1mg/mL

BNC882570-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF640R conjugate, 0.1mg/mL

BNC402570-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF640R conjugate, 0.1mg/mL

BNC402570-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF405S conjugate, 0.1mg/mL

BNC042570-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF405S conjugate, 0.1mg/mL

BNC042570-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), Biotin conjugate, 0.1mg/mL

BNCB1943-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), Biotin conjugate, 0.1mg/mL

BNCB1943-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF568 conjugate, 0.1mg/mL

BNC681943-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF568 conjugate, 0.1mg/mL

BNC681943-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF488A conjugate, 0.1mg/mL

BNC881943-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF488A conjugate, 0.1mg/mL

BNC881943-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF594 conjugate, 0.1mg/mL

BNC941943-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF594 conjugate, 0.1mg/mL

BNC941943-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF640R conjugate, 0.1mg/mL

BNC401943-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF640R conjugate, 0.1mg/mL

BNC401943-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF647 conjugate, 0.1mg/mL

BNC471943-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF647 conjugate, 0.1mg/mL

BNC471943-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF405S conjugate, 0.1mg/mL

BNC041943-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF405S conjugate, 0.1mg/mL

BNC041943-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Her-2 IHC Bio-marker control TMA

Her2a each
EUR 78
Description: Her-2 IHC Bio-marker control TMA, with breast invasive ductal carcinoma, including TNM, clinical stage and pathology grade, 10 cases/ 10 cores, replaced by Her2b

Her-2 IHC Bio-marker control TMA, with breast invasive carcinoma of no special type, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2 and Ki-67) results, 10 cases/10 cores, replacing Her2b

HER2c row: 3; column: 4; cores: 10; cases: 10
EUR 78
Description: Her-2 IHC Biomarker control tissue microarray of breast invasive carcinoma of no special type, containing 10 cases of invasive invasive carcinoma of no special type, single core per case

MELISA-TEK® Meat Species Pork Kit

510321 96 Well Ask for price

MELISA-TEK® Meat Species Ruminant Kit

510311 96 Well Ask for price

MELISA-TEK® High Sensitivity Extraction Kit

510391 96 Well Ask for price

Bovine Cardiac Phospholamban (PLN) ELISA Kit-Sandwich

EK11F897
  • Ask for price
  • Ask for price
  • 48 Test
  • 96 Tests

Porcine Cardiac Phospholamban (PLN) ELISA Kit-Sandwich

EK12F771
  • Ask for price
  • Ask for price
  • 48 Test
  • 96 Tests

Meat Speciation : EZ Pangasius™

510EZP 10 Tests Ask for price

Meat Speciation : EZ Pork™

530EZPK-10 10 Tests Ask for price

Meat Speciation : EZ Pork™ Raw

540EZPKR 10 Tests Ask for price

Porcine Cardiac Troponin I (TNNI3) ELISA Kit-Sandwich

EK12F459
  • Ask for price
  • Ask for price
  • 48 Test
  • 96 Tests

Sheep Troponin I3 Cardiac Type (TNNI3) ELISA Kit-Sandwich

EK10F934
  • Ask for price
  • Ask for price
  • 48 Test
  • 96 Tests

Horse Troponin I3 Cardiac Type (TNNI3) ELISA Kit-Sandwich

EK11F90
  • Ask for price
  • Ask for price
  • 48 Test
  • 96 Tests

Canine Troponin T2, Cardiac Type (TNNT2) ELISA Kit-Sandwich

EK12F992
  • Ask for price
  • Ask for price
  • 48 Test
  • 96 Tests

Canine Troponin I3 Cardiac Type (TNNI3) ELISA Kit-Sandwich

EK11F169
  • Ask for price
  • Ask for price
  • 48 Test
  • 96 Tests

Feline Troponin T2 Cardiac Type (TNNT2) ELISA Kit-Sandwich

EK11F260
  • Ask for price
  • Ask for price
  • 48 Test
  • 96 Tests

Feline Troponin I3, Cardiac Type (TNNI3) ELISA Kit-Sandwich

EK8F243
  • Ask for price
  • Ask for price
  • 48 Test
  • 96 Tests

Porcine Troponin T2 Cardiac Type (TNNT2) ELISA Kit-Sandwich

EK9F605
  • Ask for price
  • Ask for price
  • 48 Test
  • 96 Tests

Rat Myosin-binding protein C, cardiac-type,Cardiac MyBP-C ELISA Kit

EK5119 96 tests
EUR 739

Rat Myosin-binding protein C, cardiac-type, Cardiac MyBP-C ELISA Kit

MBS9428945-5x96Tests 5x96Tests
EUR 3385

Rat Myosin-binding protein C, cardiac-type, Cardiac MyBP-C ELISA Kit

MBS9428945-96Tests 96Tests
EUR 735

Bovine Troponin I, Cardiac Muscle (TNNI3) ELISA Kit-Sandwich

EK11F592
  • Ask for price
  • Ask for price
  • 48 Test
  • 96 Tests

Bovine Troponin T, Cardiac Muscle (TNNT2) ELISA Kit-Sandwich

EK11F594
  • Ask for price
  • Ask for price
  • 48 Test
  • 96 Tests

Rat Cardiac Troponin ELISA Kit

MBS3809733-10x96StripWells 10x96-Strip-Wells
EUR 6725

Rat Cardiac Troponin ELISA Kit

MBS3809733-48StripWells 48-Strip-Wells
EUR 550

Rat Cardiac Troponin ELISA Kit

MBS3809733-5x96StripWells 5x96-Strip-Wells
EUR 3420

Rat Cardiac Troponin ELISA Kit

MBS3809733-96StripWells 96-Strip-Wells
EUR 765

Mouse Troponin I Type 3, Cardiac (TNNI3) ELISA Kit-Sandwich

EK5F306
  • Ask for price
  • Ask for price
  • 48 Test
  • 96 Tests

Mouse Troponin T Type 2, Cardiac (TNNT2) ELISA Kit-Sandwich

EK6F148
  • Ask for price
  • Ask for price
  • 48 Test
  • 96 Tests

Chicken Troponin I, Cardiac Muscle (TNNI3) ELISA Kit-Sandwich

EK3F426
  • Ask for price
  • Ask for price
  • 48 Test
  • 96 Tests

Rabbit Troponin I Type 3, Cardiac (TNNI3) ELISA Kit-Sandwich

EK3F206
  • Ask for price
  • Ask for price
  • 48 Test
  • 96 Tests

Rabbit Troponin T Type 2, Cardiac (TNNT2) ELISA Kit-Sandwich

EK3F222
  • Ask for price
  • Ask for price
  • 48 Test
  • 96 Tests

Equine Troponin T Type 2, Cardiac (TNNT2) ELISA Kit-Sandwich

EK1F111
  • Ask for price
  • Ask for price
  • 48 Test
  • 96 Tests

Human Cardiac Troponin ELISA Kit

MBS3804762-10x96StripWells 10x96-Strip-Wells
EUR 6725

Human Cardiac Troponin ELISA Kit

MBS3804762-48StripWells 48-Strip-Wells
EUR 550

Human Cardiac Troponin ELISA Kit

MBS3804762-5x96StripWells 5x96-Strip-Wells
EUR 3420

Human Cardiac Troponin ELISA Kit

MBS3804762-96StripWells 96-Strip-Wells
EUR 765

Pig Cardiac phospholamban ELISA Kit

MBS288942-10x96StripWells 10x96-Strip-Wells
EUR 4630

Pig Cardiac phospholamban ELISA Kit

MBS288942-48StripWells 48-Strip-Wells
EUR 440

Pig Cardiac phospholamban ELISA Kit

MBS288942-5x96StripWells 5x96-Strip-Wells
EUR 2480

Pig Cardiac phospholamban ELISA Kit

MBS288942-96StripWells 96-Strip-Wells
EUR 580

Dog Cardiac phospholamban ELISA Kit

MBS2887029-10x96StripWells 10x96-Strip-Wells
EUR 4630

Dog Cardiac phospholamban ELISA Kit

MBS2887029-48StripWells 48-Strip-Wells
EUR 440

Dog Cardiac phospholamban ELISA Kit

MBS2887029-5x96StripWells 5x96-Strip-Wells
EUR 2480

If the positive rate of both IA-2AB or ZnT8Ab or both are added to the results GADAb using RIA, autoimmune T1D percentage increased from 47.9% to 78.5% .the diagnosis of autoimmune time-onset T1D Japan GADAb increased when the results obtained using the new ELISA method , compared with RIA method previously used.